[Seite 60↓]

Literaturverzeichnis

1 . National Cholesterol Education Program. Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults Circulation 1994 ; 89 (3 ): 1333-1445

2 . Aakhus S., Dahl K., Wideroe T. E. Hyperlipidemia in renal transplant patients J Intern Med 1996 ; 239 (5 ): 407-415

3 . Anitschkow N. Über die Veränderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose Beiträge zur pathologischen Anatomie und allgemeinen Pathologie 1913 (56 ): 379-404

4 . Aro A., Soimakallio S., Voutilainen E. et al. Serum lipoprotein lipid and apoprotein levels as indicators of the severity of angiographically assessed coronary artery disease Atherosclerosis 1986 ; 62 : 219-225

5 . Assmann G., Schulte H. The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease Am Heart J 1988 ; 116 : 1713-1724

6 . Austin M. A., Hokanson J. E. Epidemiology of triglycerides, small dense Low-Density Lipoprotein and Lipoprotein (a) as risk factors for coronary heart disease Med Clin North Am 1994 ; 78 (1 ): 99-112


[Seite 61↓]

7 . Avogaro P., Cazzolato G., Bittolo Bon G., Quinci G. B. Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet 1979 ; 28 : 901-903

8 . Bartens W., Wanner C. Lipoprotein (a): new insights into an atherogenic lipoprotein Clin Investig 1994 ; 72 (8 ): 558-567

9 . Betteridge D. J., Kahn M. Review of new guidelines for management of dyslipidemia Baillieres Clin Endocrinol Metab 1995 ; 9 (4 ): 867-890

10 . Bittar A. E., Ratcliffe P. J., Richardson A. J. The prevalence of hyperlipidemia in renal transplant recipients Transplantation 1990 ; 59 (6 ): 987-992

11 . Black I. W., Wilcken D. E. Decreases in apolipoprotein (a) after renal transplantation. Implications for lipoprotein (a) metabolism, Clin Chem 1992 ; 38 (3) : 353-357

12 . Boer J. M. A., Ehnholm C., Menzel H.-J. et al. Interactions between lifestyle-related factors and the apo E-polymorphismus on plasma lipids and apolipoproteins – the EARS study Arterioscler Thromb Vasc Biol 1997 ; 17 : 1675-1681

13 . Bumgardner G. L., Wilson G. A., Tso P. L. et al. Impact of serum lipids on long-term graft and patient survival after renal transplantation Transplantation 1995 ; 60 (12 ):1418-1421


[Seite 62↓]

14 . Castelao A. M., Barbera M. J., Blanco A. et al. Lipid metabolic abnormalities after renal transplantation under Cyclosporine and Prednisone immunsuppression Transplant Proc 1992 ; 24 (1 ): 96-98

15 . Cattin L., Fisicaro M., Tonizzo M. et al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults Arterioscler Thromb Vasc Biol 1997 ; 17 : 91-94

16 . Corboy J., Sutherland W. H., Walker R. J. et al. Cholesteryl ester transfer in patients with renal failure or renal transplants Kidney Int 1994 ; 46 (4 ): 1147-1153

17 . Dahlen G. H., Guyton J. R., Attar M. et al. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography Circulation 1986 ; 74 (4 ): 758-765

18 . De Lorenzo F., Mukherjee M., Kadziola Z. et al. Association of overall adiposity rather than body mass index with lipids and procoagulant factors Thromb Haemost 1998 ; 80 : 603-606

19 . Dimény E. Metabolic factors and outcome of organ transplantation Scand J Urol Nephrol 1994 ; Suppl. 159

20 . Dimény E., Fellström B., Larsson E. et al. The role of lipoprotein abnormalities in chronic vascular rejection after kidney transplantation Transplant Proc 1995 ; 27 (3) : 2036-2039


[Seite 63↓]

21 . Dimény E., Tufveson G., Lithell H. et al. The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation Eur J Clin Invest 1993 ; 23 (9 ): 572-579

22 . Dimény E., Wahlberg J., Lithell H., Fellström B. Hyperlipidemia in renal transplantation - risk factor for long-term graft outcome Eur J Clin Invest 1995 ; 25 (8 ): 574-583

23 . Divakar D., Bailey R. R., Frampton C. M. et al. Hyperlipidemia in stable renal transplant recipients Nephron 1991 ; 59 (3 ): 423-428

24 . Downey P., Maiz A., Vaccarezza A. et al. Renal transplantation and dislipidaemia: Characterization of a population and treatment with diet and low dose Lovastatin Transplant Proc 1995 ; 27 (2 ): 1803-1805

25 . Dreikorn K. Meilensteine in der Geschichte der Nierentransplantation Nieren- und Hochdruckkrankheiten 1986 ; 15 (7 ): 297-308

26 . Drueke T. B., Abdulmassih Z., Lacour B. et al. Atherosclerosis and lipid disorders after renal transplantation Kidney Int Suppl 1991 ; 31 : 24-28

27 . Durrington P. N., Hunt L., Ishola M. et al. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction Br Heart J 1986 ; 56 : 206-212


[Seite 64↓]

28 . Fellström B. The effects of lipids on graft outcome Transpl Proc 1999 ; 31 (Suppl. 7a ): 14S-15S

29 . Fulton B., Markham A. Focus on Mycophenolate Mofetil Drugs 1996 ; 51 (2 ): 278-298

30 . Ginsberg H. N. Lipoprotein metabolism and its relationship to atherosclerosis Med Clin North Am 1994 ; 78 (1 ): 1-20

31 . Goldberg I. J. Lipoprotein metabolism in normal and uremic patients Am J Kidney Dis 1993 ; 21 (1 ): 87-90

32 . Goldstein S., Duhamel G., Laudat M. H. et al. Plasma lipids, lipoproteins and apolipoproteins AI, AII and B in renal transplanted children: What risk for accelerated atherosclerosis? Nephron 1984 ; 38 : 87-92

33 . Groth C. G. Landmarks in clinical renal transplantation Surg Gynecol Obstet 1972 ; 134 (2 ): 327-328

34 . Grützmacher P., März W., Peschke B. et al. Lipoproteins and apolipoproteins during the progression of chronic renal disease Nephron 1988 ; 50 : 103-111


[Seite 65↓]

35 . Guijarro C., Massy Z. A., Kasiske B. L. Clinical correlation between renal allograft failure and hyperlipidemia Kidney Int 1995 ; 48 (Suppl. 52 ): S56-S59

36 . Havel R. J. Biology of cholesterol, lipoproteins and atherosclerosis Clin Exp Hypertens A 1989 ; 11 (5-6 ): 887-900

37 . Heidenreich S., August C., Lang D. Langzeitprobleme bei nierentransplantierten Patienten Med Klin 2000 ; 95 : 261-266

38 . Hillebrand G. F., Schlosser S., Schneeberger H. et al. No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure Transpl Proc 1999 ; 31 : 1391-1392

39 . Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 1990 ; 31 (3 ): 545-548

40 . Hohage H., Arlt M., Brückner D. et al. Effects of Cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients Clin Transplantation 1997 ; 11 : 225-230

41 . Holdaas H., Hartmann A., Stenstrom J. et al. Effect of Fluvastatin for safely lowering atherogenic lipids in renal transplant patients recieving Cyclosporine Am J Cardiol 1995 ; 76 : 102A-106A


[Seite 66↓]

42 . Hopkins P. N., Williams R. R. A survey of 246 suggested coronary risk factors Atherosclerosis 1981 ; 40 (1 ): 1-52

43 . Hörl W. H., Riegel W., Wanner C. et al. Endocrine and metabolic abnormalities following kidney transplantation Klin Wochenschr 1989 ; 67 : 907-918

44 . Hricik D. E. Posttransplant hyperlipidemia: the treatment dilemma Am J Kidney Dis 1994 ; 23 (5 ): 766-771

45 . Inkeles S., Eisenberg M. P. H., Eisenberg D. Hyperlipidemia and coronary atherosclerosis: a review Medicine Baltimore 1981 ; 60 (2 ): 110-123

46 . Irish A. B., Simons L. A., Savdie E. et al Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation Aust N Z J Med 1992 ; 22 (3 ): 243-248

47 . Isoniemi H., Tikkanen M., Häyry P. et al. Lipid profiles with triple drug immunsuppressive therapy and with double drug combinations after renal transplantation and stable graft function Transplant Proc 1991 ; 23 (1 Pt 2 ): 1029-1031

48 . Kardia S. L. R., Haviland M. B., Ferrell R. E., Sing C. F. The relationship between risk factor levels and presence of coronary artery calcification is dependent on apolipoprotein E genotype Arterioscler Thromb Vasc Biol 1999 ; 19 : 427-435


[Seite 67↓]

49 . Kirste G. Stand und Entwicklung der Nierentransplantation Zentralbl Chir 1993 ; 118 (3 ): 113-117

50 . Kostner G. M., Avogaro P., Cazzolato G. et al. Lipoprotein Lp(a) and the risk for myocardial infarction Atherosclerosis 1981 ; 38 : 51-61

51 . Krauss R., Winston M. Obesity – impact on cardiovascular disease Circulation 1998 ; 98 : 1472-1476

52 . Kronenberg F., Dieplinger H., König P., Utermann G. Lipoprotein metabolism in renal replacement therapie - a review Isr J Med Sci 1996 ; 32 (6 ): 371-389

53 . Lye W. C., Hughes K., Leong S. O. et al. Abnormal Lipoprotein(a) and lipid profiles in renal allograft recipients: Effects of treatment with Pravastatin Transplant Proc 1995 ; 27 (1 ): 977-978

54 . Maher V. M., Brown B. G., Marcovina S. M. et al. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of Lipoprotein (a) JAMA 1995 ; 274 (22 ): 1771-1774

55 . Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 1988 ; 240 : 622-630


[Seite 68↓]

56 . Margolis S. Clinical-review: diagnosis and management of abnormal plasma lipids J Clin Endocrinol Metab 1990 ; 70 (4 ): 821- 825

57 . Markell M. S., Armenti V., Danovitch G., Sumrani N. Hyperlipidemia and glucose intolerance in the postrenal transplant patient J Am Soc Nephrol 1994 ; 4 (1 ): 37-47

58 . Markell M. S., Sumrani N., DiBenedetto A., Friedman E. A. Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients Am J Kidney Dis 1993 ; 22 (1 ): 233-239

59 . Merion R. M., Twork A. M., Rosenberg L. et al. Obesity and renal transplantation Surg Gynecol Obstet 1991 ; 172 (5 ): 367-376

60 . Moorhead J. F. Lipids and progressive kidney disease Kidney Int Suppl 1991 ; 31 : S35-S40

61 . Muntner P., Coresh J., Clinton Smith J. et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study Kidney Int 2000 ; 58 : 293-301

62 . Nelson J., Beauregard H., Gelinas M. et al. Rapid improvement of hyperlipidemia in kidney transplant patients with a multifactorial hypolipidemic diet Transplant Proc 1988 ; 20 (6 ): 1264-1270


[Seite 69↓]

63 . Noma A., Yokosuka T., Kitamura K. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease Atherosclerosis 1983 ; 49 : 1-7

64 . Olbricht C. J. Pathophysiologie und Therapie von Lipidstoffwechselstörungen bei Nierenerkrankungen Klin Wochenschr 1991 ; 69 (11 ): 455-462

65 . Pollock C. A., Mahony J. F., Ong C. S. et al. Hyperlipidemia in renal transplant recipients: Does it matter and can we treat it? Transplant Proc 1995 ; 27 (3 ): 2152-2153

66 . Ponticelli C., Barbi G. L., Cantaluppi A. Lipid disorders in renal transplant recipients Nephron 1978 ; 20 : 189-195

67 . Pschyrembel - Klinisches Wörterbuch , 257. Auflage Walter de Gruyter Berlin New York 1994

68 . Raine A. E. G., Margreiter R., Brunner F. P. et al. Report on management of renal failure in Europe Nephrol Dial Transplant 1992 ; Suppl. 2 : 7-35

69 . Riesen W. F., Mordasini R. Hyperlipidemia in renal failure: Phenotypes and pathogenetic mechanisms Contr Nephrol 1984 ; 41 : 312-320


[Seite 70↓]

70 . Scanu A. M. Physiopathology of plasma lipoprotein metabolism Kidney Int 1991 ; 39 (Suppl. 31 ): S3-S7

71 . Scanu A. M., Fiess G. M. Lipoprotein (a) - heterogenity and biological relevance J Clin Invest 1990 ; 85 : 1709-1715

72 . Schmitz G., Lackner K. J. Lipid-lowering therapy - implications for the prevention of atherosclerosis Basic Res Cardiol 1994 ; 89 (Suppl. 1 ): 185-198

73 . Schwandt P., Richter W. O. Handbuch der Fettstoffwechselstörungen Schattauer Verlag Stuttgart New York 1995

74 . Segarra A., Chacon P., Martin M. et al. Serum lipoprotein (a) levels in patients with chronic renal failure - evolution after renal transplantation and relationship with other parameters of lipoprotein metabolism: a prospective study Nephron 1995 ; 69 (1 ): 9-13

75 . Sirtl C., Jesch F. Anästhesiologisches Notizbuch , 3. Auflage Wiss. Verl.-Abtlg. Abbott GmbH Wiesbaden

76 . Steinmetz A., Utermann G. Lipoprotein (a) als Risikofaktor für Arteriosklerose Internist 1992 ; 33 : 24-30


[Seite 71↓]

77 . Surdacki A., Wieczorek-Surdacka E., Sulowicz W., Dubiel J. S. Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy Nephrol Dial Transplant 1995 ; 10 : 1218-1223

78 . Sutherland W. H., Corboy J., Walker R.J. et al. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant Nephrol Dial Transplant 1995 ; 10 (3 ): 358-365

79 . Telci A., Salmayenli N., Aydin A. E. et al. Serum lipids and apolipoprotein concentrations and plasma fibronectin concentrations in renal transplant patients Eur J Clin Chem Biochem 1992 ; 30 (12 ): 847-850

80 . The Lipid Research Clinics Program Epidemiology Committee Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study Circulation 1979 ; 60 (2 ): 427-439

81 . Traindl O., Reading S., Franz M. et al . Treatment of hyperlipidemic kidney graft recipients with Lovastatin: Effect on LDL-cholesterol and Lipoprotein (a) Nephron 1992 ; 62 : 394-398

82 . Tribble D. L. Lipoprotein oxidation in dyslipidemia: Insights into general mechanisms affecting lipoprotein oxidative behaviour Curr Opin Lipidol 1995 ; 6 (4 ): 196-208

83 . Utermann G. The mysteries of Lipoprotein (a) Science 1989 ; 246 : 904-910


[Seite 72↓]

84 .: Vathsala A., Weinberg R. B., Schoenberg L. et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients, Transplantation 1989 ; 48 (1 ). 37-43

85 . Walden C. C., Hegele R. A. Apolipoprotein E in Hyperlipidemia Ann Intern Med 1994 ; 120 (12 ): 1026-1036

86 . Wanner C., Bartens W., Galle J. Clinical utility of antilipidemic therapies in chronic renal allograft failure Kidney Int 1995 ; 48 (Suppl. 52 ): S60-S62

87 . Wanner C., Frommherz K., Hörl W. H. Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects Cardiology 1991 ; 78 (3 ): 202-217

88 . Webb A. T., Plant M., Reaveley D. A. et al. Lipid and lipoprotein (a) concentrations in renal transplant recipients Nephrol Dial Transplant 1992 ; 7 : 636-641

89 . Wheeler D. C., Morgan R., Thomas D. M. et al. Factors influencing plasma lipid profiles including Lipoprotein (a) concentrations in renal transplant recipients Transpl Int 1996 ; 9 : 221-226

90 . Wissing K. M., Abramowicz D., Broeders N. et al. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection Transplantation 2000 ; 70 (3 ): 464-472


[Seite 73↓]

91 . Wüthrich R. P. Nierentransplantation , 2. Auflage Springer Verlag 1995


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
05.03.2004